Squamous Cell Carcinoma (SCC) is a form of skin cancer that originates from the epidermal layer of the skin. It is the second most common form of skin cancer, accounting for up to 20% of all cases. SCC typically appears as firm, red nodules that can be scaly and may crust, bleed, or ulcerate. It is most commonly found on areas of the skin that are frequently exposed to the sun, such as the face, ears, neck, and arms. The exact cause of SCC is unknown, however it is thought to be linked to long-term exposure to ultraviolet (UV) radiation from the sun or tanning beds. Other factors that may increase the risk of developing SCC include a weakened immune system, chronic skin irritation, human papillomavirus (HPV) infection, and certain chemical exposures. Treatment for SCC typically involves surgical removal of the tumor. However, if the tumor is large, or if it has spread to other areas of the body, additional treatments such as radiation therapy, chemotherapy, or immunotherapy may be necessary. In some cases, doctors may also recommend lifestyle changes such as wearing sun protective clothing and using sunscreen to help lower the risk of recurrence. The prognosis for SCC is generally good, especially for those with early diagnosis and treatment. However, if the tumor is not treated early, it can spread to other areas of the body, making it more difficult to treat. Therefore, it is important to remain vigilant and visit your dermatologist regularly for skin cancer screenings.
Title : Principles of facial trauma surgery 2026
Steven J Traub, American Institute of Oral Biology, United States
Title : Artificial intelligence in dentistry: Overcoming diagnostic challenges in modern practice
Khoa Le, Eyes of AI, Australia
Title :
Zvi G Loewy, New York Medical College, United States
Title : Bilateral reconstruction of the midface (Le Fort I/II) with microvascularized fibular flap: A proposed new technique
Laurindo Moacir Sassi, Erasto Gaertner Hospital Cancer Center and Mackenzie Evangelical University Hospital, Brazil
Title :
David Geoffrey Gillam, Queen Mary University of London, United Kingdom
Title : Peri implantitis: The implant era’s greatest challenge and the road ahead
Preetinder Singh, Academy of Oral Surgery, United States